Jim Shannon MP: written questions
4 Jul 2026–18 Nov 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 15 Nov 2026
- Last successful import
- 15 Nov 2026
- Records dated through
- 13 Nov 2026
- Selected period
- Reporting year 3: 4 Jul 2026 to 18 Nov 2026
- Completeness
- Published snapshot: 23,625 records in the source window 17 Aug 2026 to 15 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
110 published records · newest first.
Written questions
Meningitis: VaccinationDepartment of Health and Social CareTabled 10 Nov 2026Awaiting answerUIN 41080More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to increase the take-up of meningitis vaccines.
Answer: No published answer in this record yet.
Original Parliament recordBone Diseases: ResearchDepartment of Health and Social CareTabled 10 Nov 2026Awaiting answerUIN 41079More
Question: To ask the Secretary of State for Health and Social Care, what research funding is allocated to improving outcomes for patients with osteogenesis imperfecta.
Answer: No published answer in this record yet.
Original Parliament recordSarcoidosis and Addison's DiseaseDepartment of Health and Social CareTabled 3 Nov 2026Awaiting answerUIN 40160More
Question: To ask the Secretary of State for Health and Social Care, how many specialist clinics exist for patients with sarcoidosis; and what assessment she has made of the adequacy of care pathways for people diagnosed with Addison’s disease.
Answer: No published answer in this record yet.
Original Parliament recordSepsis: Health EducationDepartment of Health and Social CareTabled 3 Nov 2026AnsweredUIN 40159More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to increase the level awareness of sepsis among healthcare professionals and the public.
Answer: I refer the Hon Member to the answer provided in the House of Lords on 14 September in response to Question HL2897.
Answered 10 Nov 2026
Original Parliament recordCancer: Young PeopleDepartment of Health and Social CareTabled 29 Oct 2026AnsweredUIN 39166More
Question: To ask the Secretary of State for Health and Social Care, what steps she taking to support research into the effects of processed foods and early antibiotic use, including research on the potential contribution to increasing cancer rates in the young.
Answer: In relation to processed foods, the Scientific Advisory Committee on Nutrition’s (SACN’s) rapid evidence update on processed foods found that the categories of processed food consistently associated with adverse health outcomes, including cancer, included...
Answered 4 Nov 2026
Original Parliament recordMental Health Services: Northern IrelandDepartment of Health and Social CareTabled 29 Oct 2026AnsweredUIN 39165More
Question: To ask the Secretary of State for Health and Social Care, what discussions she has had with the Northern Ireland Executive on support for effective mental health support resourcing and workforce levels.
Answer: As a Department of State, we work collaboratively with the devolved administrations to drive forward our objective of supporting people to lead more independent, healthier lives for longer.The Government has already made progress in increasing the number ...
Answered 5 Nov 2026
Original Parliament recordMaternity Services: StaffDepartment of Health and Social CareTabled 29 Oct 2026AnsweredUIN 39164More
Question: To ask the Secretary of State for Health and Social Care, whether she plans to take steps to address staffing shortages and ensure maternity staff are adequately compensate for the additional hours they work.
Answer: I refer the Hon. Member to the last session of departmental oral questions on 20 October, when issues in relation to maternity staffing in England were discussed at length.Any future decisions on staff pay will be announced in the usual way in due course.
Answered 4 Nov 2026
Original Parliament recordMotor Neurone DiseaseDepartment of Health and Social CareTabled 28 Oct 2026AnsweredUIN 38896More
Question: To ask the Secretary of State for Health and Social Care, what assessment she has made of causes of delays in MND diagnosis, particularly in women.
Answer: The Government is developing a motor neurone disease fast track pathway and diagnosis will be considered as part of it. I refer the Hon. Member to the answer provided on 7 September in response to Question 22114 and the answer provided on 14 September in ...
Answered 5 Nov 2026
Original Parliament recordAutoimmune Diseases: Health ServicesDepartment of Health and Social CareTabled 28 Oct 2026AnsweredUIN 38752More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that expert clinical guidance and patient voice representation for rare autoimmune rheumatic diseases are retained at a national level.
Answer: I refer the Hon. Member to the answer provided on 26 October in response to Question 36778. In regards to clinical reference groups, I refer the Hon. Member to the answer provided on 24 August in response to the Question HL1992.
Answered 4 Nov 2026
Original Parliament recordClinical Reference GroupsDepartment of Health and Social CareTabled 28 Oct 2026AnsweredUIN 38751More
Question: To ask the Secretary of State for Health and Social Care, what the future role, governance and hosting of specialised commissioning Clinical Reference Groups will be following the abolition and restructuring of NHS England.
Answer: I refer the Hon. Member to the answer provided on 26 October in response to Question 36778. In regards to clinical reference groups, I refer the Hon. Member to the answer provided on 24 August in response to the Question HL1992.
Answered 4 Nov 2026
Original Parliament recordRare Diseases: DiagnosisDepartment of Health and Social CareTabled 28 Oct 2026Awaiting answerUIN 38750More
Question: To ask the Secretary of State for Health and Social Care, what support her Department is providing for the development of AI-enabled decision-support tools to accelerate earlier diagnosis for rare conditions that do not have a known genetic cause.
Answer: No published answer in this record yet.
Original Parliament recordAutoimmune Diseases: Health ServicesDepartment of Health and Social CareTabled 28 Oct 2026AnsweredUIN 38749More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to address variations in commissioning, funding and staffing for specialist rare autoimmune rheumatic disease networks across Integrated Care Boards.
Answer: I refer the Hon. Member to the answer provided on 26 October in response to Question 36778. In regards to clinical reference groups, I refer the Hon. Member to the answer provided on 24 August in response to the Question HL1992.
Answered 4 Nov 2026
Original Parliament recordMental Illness: Medical TreatmentsDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38542More
Question: To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential benefits of developing additional evidence-based treatment options for patients with treatment-resistant mental health conditions, including the
Answer: I refer the Hon. Member to the answer provided on 19 October in response to Question 31239.
Answered 2 Nov 2026
Original Parliament recordMental Illness: PsilocybinDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38541More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to support clinical research into psilocybin-based treatments for mental health conditions, and how the findings of such research will inform decisions about future patient
Answer: I refer the Hon. Member to the answer provided on 19 October in response to Question 31239.
Answered 2 Nov 2026
Original Parliament recordDepressive Illnesses: PsilocybinDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38540More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential role of psilocybin-assisted therapy for patients with treatment-resistant depression.
Answer: I refer the Hon. Member to the answer provided on 19 October in response to Question 31239.
Answered 2 Nov 2026
Original Parliament recordAutoimmune Diseases: Health ServicesDepartment of Health and Social CareTabled 27 Oct 2026AnsweredUIN 38248More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that dedicated national clinical leadership is retained to guide policy, clinical standards, and specialist care networks for the 70,000 people living with ra
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordRare Diseases: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37769More
Question: To ask the Secretary of State for Health and Social Care, if she will assess the potential merits of commissioning a national Rare Disease Patient Experience Survey, modelled on the Cancer Patient Experience Survey, to identify regional variation and trac
Answer: I refer the Hon Member to the answer provided on 22 September in response to Question 26638.
Answered 2 Nov 2026
Original Parliament recordRare Diseases: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37768More
Question: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to establish a successor rare disease strategy and maintain national policy commitments after the UK Rare Diseases Framework concludes in January 2027.
Answer: I refer the Hon Member to the answer provided on 22 September in response to Question 26638.
Answered 2 Nov 2026
Original Parliament recordRheumatology: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37767More
Question: To ask the Secretary of State for Health and Social Care, what data the Government has on the prevalence, incidence and patient experience of those diagnosed with rare autoimmune rheumatic diseases; and what government body will oversee this data followin
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordRheumatology: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37766More
Question: To ask the Secretary of State for Health and Social Care, what consideration the Government has given to allocating additional funding to establish specialised rheumatology networks to improve knowledge-sharing among healthcare practitioners.
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordRheumatology: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37765More
Question: To ask the Secretary of State for Health and Social Care, what steps the Government is taking to improve care coordination for patients with rare autoimmune rheumatic diseases as a result of the publication of the NICE Quality Standard for Rare Disease.
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordRheumatology: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37764More
Question: To ask the Secretary of State for Health and Social Care, when her Department plans to publish the updated national service specification for specialised rheumatology; and what steps she is taking to ensure that revised standards for multidisciplinary car
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordRheumatology: Health ServicesDepartment of Health and Social CareTabled 26 Oct 2026AnsweredUIN 37763More
Question: To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the future status, governance, and hosting of the Specialised Rheumatology Clinical Reference Group following the restructuring and integration of NHS Eng
Answer: In line with the identical questions received on 21 October from the Hon. Member for Harrow East, I refer the Hon. Member to the answer provided on 26 October in response to Question 36778.
Answered 2 Nov 2026
Original Parliament recordStrokes: Health ServicesDepartment of Health and Social CareTabled 22 Oct 2026AnsweredUIN 37227More
Question: To ask the Secretary of State for Health and Social Care, what measures exist to support patients recovering from stroke.
Answer: The Hon. Member has asked several questions about the diagnosis and treatment of several well-known conditions. For each of these, I refer him below to the most recent comprehensive answer provided in the House on the condition in question, or to the publ...
Answered 29 Oct 2026
Original Parliament recordSickle Cell Diseases: Health ServicesDepartment of Health and Social CareTabled 22 Oct 2026AnsweredUIN 37226More
Question: To ask the Secretary of State for Health and Social Care, what steps she is taking to help reduce inequalities in care for those with thalassemia.
Answer: The Hon. Member has asked several questions about the diagnosis and treatment of several well-known conditions. For each of these, I refer him below to the most recent comprehensive answer provided in the House on the condition in question, or to the publ...
Answered 29 Oct 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2026–18 Nov 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →